Related Experiment Video
Updated: May 27, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
No vaccine against HIV yet--are we not perfectly equipped?
1Department of Pathology and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. mahendersh@juno.com
Abstract:
Enormous effort has been devoted to the development of a vaccine against human immunodeficiency virus (HIV). But it is proving to be an unprecedented challenge to create an effective vaccine mainly due to the high genetic variability of the virus and the necessity of cytotoxic T lymphocytes (CTL) for containing the infection. Currently pursued vaccine strategies appear to induce CTL in nonhuman primate models but in the early clinical trials, these strategies fail to fully control the viral infection. New strategies that can cover the vast genetic diversity of HIV are needed for the development of a potent vaccine.
Related Concept Videos
Retrovirus Life Cycles
Viral Mutations
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Vaccines
Inhibitors of Virion Maturation and Assembly

